ロード中...
The Prognostic Impact of HER2 Genetic and Protein Expression in Pancreatic Carcinoma—HER2 Protein and Gene in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) is a lethal and clinically heterogeneous disease with a limited benefit from human epidermal growth factor receptor 2 (HER2)-targeted therapy. Recently, some studies have addressed the antitumoral effect of novel anti-HER2 drugs in HER2 low-expressing tumors....
保存先:
| 出版年: | Diagnostics (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8065582/ https://ncbi.nlm.nih.gov/pubmed/33916543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11040653 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|